[1]
Fazio, F. et al. 2023. MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS. Mediterranean Journal of Hematology and Infectious Diseases. 15, 1 (Aug. 2023), e2023047. DOI:https://doi.org/10.4084/MJHID.2023.047.